Inhibikase Therapeutics, Inc. (IKT)

NASDAQ: IKT · Real-Time Price · USD

1.520

-0.060 (-3.80%)

Aug 1, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2017 - 2018
Protein Kinase Inhibitor Therapeutics	260.50K	Log In	Log In	Log In	Log In	Upgrade
Protein Kinase Inhibitor Therapeutics Growth	111.03%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2017 - 2018
United States	260.50K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	111.03%	Log In	Log In	Log In	Log In	Upgrade